Ajanta Pharma will hold its Forty-Seventh Annual General Meeting on July 16, 2026, at 11:00 a.m. IST via video conferencing. The meeting will be conducted in compliance with the Companies Act, 2013 and relevant circulars issued by the Ministry of Corporate Affairs and the Securities and Exchange Board of India. This virtual format allows shareholders to participate remotely while adhering to regulatory standards.

The company has established key dates for shareholder participation and documentation. For the purpose of dispatching the Annual Report for FY 2025-26 and the Notice convening the AGM, the beneficiary position of shareholders will be considered as on Friday, June 12, 2026. Additionally, the cut-off date for determining the eligibility of members to vote on the resolutions proposed at the meeting is Thursday, July 9, 2026.

The Notice convening the AGM and the Annual Report for FY 2025-26 will be dispatched to members in due course. These documents will also be made available on the company's website, ensuring accessibility for all stakeholders. The intimation was filed pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Key AGM Details

The meeting agenda will cover the resolutions proposed to be passed during the 47th AGM. Shareholders are advised to ensure their holdings are updated with the depositories to facilitate smooth participation and receipt of statutory documents.

Aayush Agrawal, a promoter of Ajanta Pharma , has created a pledge on 11,11,111 shares to secure a new loan, according to a regulatory filing submitted on June 12, 2026. The shares were pledged in favor of RBL Bank Ltd. The disclosure was made in compliance with Regulation 31(1) and 31(2) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.

The filing details the shareholding and encumbrance status of various promoter entities. Aayush Agrawal, as trustee of the Aayush Agrawal Trust, holds a total of 1,41,12,924 shares, accounting for 11.30% of the company. Following the pledge creation on June 10, 2026, the total encumbered holding for this entity stands at 1,25,56,198 shares, representing 10.05% of the total share capital.

The transaction involved two separate pledge creations on the same date. The first pledge covered 8,92,860 shares, and the second covered 2,18,251 shares. Both were created for the purpose of a new loan.

Other promoter entities listed in the disclosure include Gabs Investments Pvt Ltd, which holds 27,70,000 encumbered shares, and trusts associated with key individuals such as Yogesh M Agrawal, Rajesh M Agrawal, and Ravi P Agrawal. While some entities hold existing encumbered shares, the recent pledge activity is specific to Aayush Agrawal as trustee of the Aayush Agrawal Trust.

The following table summarizes the shareholding and encumbrance details disclosed by the promoters:

The document was signed by Aayush Agrawal, Trustee of the Aayush Agrawal Trust, and addressed to BSE Limited and the National Stock Exchange of India.